BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vivarelli M, Montalti R, Risaliti A. Multimodal treatment of hepatocellular carcinoma on cirrhosis: An update. World J Gastroenterol 2013; 19(42): 7316-7326 [PMID: 24259963 DOI: 10.3748/wjg.v19.i42.7316]
URL: https://www.wjgnet.com/1948-5182/full/v19/i42/7316.htm
Number Citing Articles
1
Edris M. Alkozai, Robert J. Porte, Jelle Adelmeijer, Alberto Zanetto, Paolo Simioni, Marco Senzolo, Ton Lisman. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinomaPlatelets 2015; 26(6): 577 doi: 10.3109/09537104.2014.961415
2
Ahmet Gurakar, Serkan Dogan. Liver Transplantation Update: 2014Euroasian Journal of Hepato-Gastroenterology 2015; 5(2): 98 doi: 10.5005/jp-journals-10018-1144
3
Stefanie J. Hectors, Sara Lewis, Paul Kennedy, Octavia Bane, Daniela Said, Maxwell Segall, Myron Schwartz, Edward Kim, Bachir Taouli. Assessment of Hepatocellular Carcinoma Response to 90Y Radioembolization Using Dynamic Contrast Material–enhanced MRI and Intravoxel Incoherent Motion Diffusion-weighted ImagingRadiology: Imaging Cancer 2020; 2(4): e190094 doi: 10.1148/rycan.2020190094
4
Dario Lorenzin, Riccardo Pravisani, Cosimo Alex Leo, Walter Bugiantella, Giorgio Soardo, Alessia Carnelutti, Baccarani Umberto, Andrea Risaliti. Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 RadioembolizationCancer Biotherapy and Radiopharmaceuticals 2016; 31(2): 65 doi: 10.1089/cbr.2015.1905
5
Concetta Panebianco, Chiara Saracino, Valerio Pazienza. Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progressionTumor Biology 2014; 35(8): 7307 doi: 10.1007/s13277-014-2075-x
6
Huanan Li, Yong Sun, Jie Liang, Yujiang Fan, Xingdong Zhang. pH-Sensitive pullulan–DOX conjugate nanoparticles for co-loading PDTC to suppress growth and chemoresistance of hepatocellular carcinomaJournal of Materials Chemistry B 2015; 3(41): 8070 doi: 10.1039/C5TB01210D
7
Yan Sun, Hai Sun. Retracted:Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5Journal of Cellular Physiology 2020; 235(3): 2963 doi: 10.1002/jcp.29202
8
Akanksha Dubey, Jayanthi Sivaraman. Comparative Therapeutic Approaches for Hepatocellular Carcinoma-A Concise ReviewResearch Journal of Pharmacy and Technology 2023; : 4447 doi: 10.52711/0974-360X.2023.00726
9
Xin Wang, Xinyi Casuarine Low, Weixin Hou, Lissa Nurrul Abdullah, Tan Boon Toh, Masturah Mohd Abdul Rashid, Dean Ho, Edward Kai-Hua Chow. Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem CellsACS Nano 2014; 8(12): 12151 doi: 10.1021/nn503491e
10
Sonja Gordic, Mathilde Wagner, Riccardo Zanato, Stefanie Hectors, Cecilia Besa, Shingo Kihira, Edward Kim, Bachir Taouli. Prediction of hepatocellular carcinoma response to 90Yttrium radioembolization using volumetric ADC histogram quantification: preliminary resultsCancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0216-6
11
Sidrah Khan, Alexis Chidi, Katherine Hrebinko, Christof Kaltenmeier, Ibrahim Nassour, Richard Hoehn, David Geller, Allan Tsung, Samer Tohme. Readmission After Surgical Resection and Transplantation for Hepatocellular Carcinoma: A Retrospective Cohort StudyThe American Surgeon 2022; 88(1): 83 doi: 10.1177/0003134820973739
12
Abdulrahman Ahmed Mahmood, Jianqi Zhang, Rufang Liao, Xiwei Pan, Dan Xu, Haibo Xu, Qibing Zhou. Evaluation of non-targeting, C- or N-pH (low) insertion peptide modified superparamagnetic iron oxide nanoclusters for selective MRI of liver tumors and their potential toxicity in cirrhosisRSC Advances 2019; 9(25): 14051 doi: 10.1039/C9RA02430A
13
Xiaolei Zhang, Shuang Liu, Congle Shen, Yali Wu, Ling Zhang, Xiangmei Chen, Fengmin Lu. DNA methylation consistency implicates the primary tumor cell origin of recurrent hepatocellular carcinomaEpigenomics 2015; 7(4): 581 doi: 10.2217/epi.15.23
14
Lisha Mou, Zuhui Pu, Yongxiang Luo, Ryan Quan, Yunhu So, Hui Jiang. Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysisFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1036562
15
Madhukar S. Patel, Rachel Kohn, Johannes R. Kratz, Jigesh A. Shah, James F. Markmann, Parsia A. Vagefi. The Race to Liver Transplantation: A Comparison of Patients With and Without Hepatocellular Carcinoma from Listing to Post-TransplantationJournal of the American College of Surgeons 2015; 220(6): 1001 doi: 10.1016/j.jamcollsurg.2014.12.050
16
LEVAN BENASHVILI, TAMAR TURMANIDZE, EVGENI ASATIANI. ROLE OF DIABETES AND NONALCOHOLIC FATTY LIVER DISEASE FOR HCC DEVELOPMENTEXPERIMENTAL & CLINICAL MEDICINE GEORGIA 2022;  doi: 10.52340/jecm.2022.717
17
Juliane Schelhorn, Jan Best, Marcus P. Reinboldt, Alexander Dechêne, Guido Gerken, Marcus Ruhlmann, Thomas C. Lauenstein, Gerald Antoch, Sonja Kinner. Does diffusion‐weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd‐EOB‐DTPA with and without DWIJournal of Magnetic Resonance Imaging 2015; 42(3): 818 doi: 10.1002/jmri.24827
18
YULIANG WANG, YINLONG WANG, HONG MU, TAO LIU, XIAOBO CHEN, ZHONGYANG SHEN. Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cellsMolecular Medicine Reports 2015; 11(5): 3361 doi: 10.3892/mmr.2015.3239
19
Marco Le Grazie, Maria Rosa Biagini, Mirko Tarocchi, Simone Polvani, Andrea Galli. Chemotherapy for hepatocellular carcinoma: The present and the futureWorld Journal of Hepatology 2017; 9(21): 907-920 doi: 10.4254/wjh.v9.i21.907
20
Fan Zhang, Jun Yan, Xiao-Bin Feng, Feng Xia, Xiao-Wu Li, Kuan-Sheng Ma, Ping Bie. Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort studyWorld Journal of Gastroenterology 2015; 21(35): 10159-10165 doi: 10.3748/wjg.v21.i35.10159
21
Li Zhen, Ning Shijie, Zhang Shuijun. Tumor PHD2 Expression Is Correlated With Clinical Features and Prognosis of Patients With HCC Receiving Liver ResectionMedicine 2014; 93(29): e179 doi: 10.1097/MD.0000000000000179
22
Kazuhiro Ezaka, Mitsuro Kanda, Hiroyuki Sugimoto, Dai Shimizu, Hisaharu Oya, Shuji Nomoto, Satoshi Sueoka, Yuri Tanaka, Hideki Takami, Ryoji Hashimoto, Yukiyasu Okamura, Suguru Yamada, Tsutomu Fujii, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative HepatectomyAnnals of Surgical Oncology 2015; 22(S3): 1499 doi: 10.1245/s10434-015-4695-9
23
Cancer and its Management2014; : 290 doi: 10.1002/9781118468753.ch15
24
Yifeng Tao, Feng Lin, Ruidong Li, Jie Shen, Zhengxin Wang. Prolyl hydroxylase-2 inhibits liver tumor cell proliferation and cyclin D1 expression in a hydroxylase-dependent mannerThe International Journal of Biochemistry & Cell Biology 2016; 77: 129 doi: 10.1016/j.biocel.2016.05.022
25
Rafael FERNANDES-FERREIRA, Graciele Domitila TENANI, Marcela Augusta de Souza PINHEL, Ana Margarida Coelho ABRANTES, Maria Filomena Rabaça Roque BOTELHO, Rita de Cássia Martins Alves da SILVA, Dorotéia Rossi Silva SOUZA, Renato Ferreira da SILVA. GENES EXPRESSION AND SERUM BIOMARKERS FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA, CIRRHOSIS AND HEPATITIS CArquivos de Gastroenterologia 2022; 59(3): 394 doi: 10.1590/s0004-2803.202203000-71
26
Satoshi Sueoka, Mitsuro Kanda, Hiroyuki Sugimoto, Dai Shimizu, Shuji Nomoto, Hisaharu Oya, Hideki Takami, Kazuhiro Ezaka, Ryoji Hashimoto, Yuri Tanaka, Yukiyasu Okamura, Suguru Yamada, Tsutomu Fujii, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular CarcinomaAnnals of Surgical Oncology 2015; 22(S3): 1453 doi: 10.1245/s10434-015-4524-1
27
Liping Luo, Ronghua Yan, Qingjing Zeng, Yinglin Long, Xuqi He, Kai Li, Erjiao Xu. Radiofrequency Ablation of Hepatocellular Carcinomas Adjacent to the Gallbladder Without Isolation Under Contrast-Enhanced Ultrasound Monitoring: A Comparative Study with Long Term Follow-UpJournal of Hepatocellular Carcinoma 2023; : 631 doi: 10.2147/JHC.S388738
28
Xiaomeng Xie, Mingjie Yao, Xiangmei Chen, Weiquan Lu, Quanjun Lv, Kaijuan Wang, Ling Zhang, Fengmin Lu. Reduced Red Blood Cell Count Predicts Poor Survival After Surgery in Patients With Primary Liver CancerMedicine 2015; 94(8): e577 doi: 10.1097/MD.0000000000000577
29
Dashuai Yang, Yang Su, Fangrui Zhao, Chen Chen, Kailiang Zhao, Xiangyun Xiong, Youming Ding. A Practical Nomogram and Risk Stratification System Predicting Cancer-Specific Survival for Hepatocellular Carcinoma Patients With Severe Liver FibrosisFrontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.920589
30
Nam-Chul Jung, Jun-Ho Lee, Hyun-Ji Choi, Sung-Uk Hwang, Jie-Young Song, Han Geuk Seo, Jinjung Choi, Sang Youn Jung, Sung Gu Han, Dae-Seog Lim. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in MiceImmunological Investigations 2016; 45(6): 553 doi: 10.1080/08820139.2016.1183025
31
Clara Tan-Tam, Stephen W Chung. Minireview on laparoscopic hepatobiliary and pancreatic surgeryWorld Journal of Gastrointestinal Endoscopy 2014; 6(3): 60-67 doi: 10.4253/wjge.v6.i3.60